coadministration

BIOLOGICAL3 trials

Sponsors

China National Biotec Group Company Limited, The Surgeon General

Conditions

COVID-19HIV/AIDSHemolysisRabies

Phase 1

RV 591 RAPIDVAX

Active, not recruitingPACTR202311679101744

The Surgeon GeneralHIV/AIDS

Start: 2023-12-19Target: 50Updated: 2026-08-03

Phase 4

Immunogenicity and Safety of an Inactivated SARS-CoV-2 Vaccine (Sinopharm BBIBP-CorV) Coadministered With Rabies Vaccine

China National Biotec Group Company LimitedCOVID-19, Rabies

Start: 2022-07-21End: 2023-06-30Target: 360Updated: 2022-07-29

Immunogenicity and Safety of BBIBP-Corv Coadministered With PPV23 and IIV4 in Hemodialysis Population

China National Biotec Group Company LimitedCOVID-19, Hemolysis

Start: 2022-08-05End: 2023-07-30Target: 1200Updated: 2022-08-30